Source: Amplion Blog

Amplion Blog Seed and Series A Biotech Funding: 2023

So far this year, Amplion has tracked 67 Seed and Series A investments into early-stage biotechs - down from 92 or a 27% decrease during the same period last year. That said, the biotech sector continues to witness rapid advancements, with numerous early-stage companies securing substantial investments to fuel their groundbreaking research and development efforts. [...]The post Seed and Series A Biotech Funding: 2023 appeared first on Amplion.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Chris Capdevila's photo - CEO of Amplion

CEO

Chris Capdevila

CEO Approval Rating

90/100

Read more